Publication | Closed Access

Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma

Tim-3 Or/and Pd-1Cancer ImmunosurveillanceHepatocellular CarcinomaImmunologyHbv-related Hepatocellular CarcinomaHepatitisLiver CancerImmunotherapyMedicineRadiation OncologyTumor MicroenvironmentViral OncologyTumor-infiltrating Lymphocytes